# Enjosim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enjosim

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.enjosim.com/
- Total disclosed funding: $14M
- Latest round: Series A (Dec 25, 2025)
- Investors on record: 5

## About

Based in Shanghai, China and established in 2021, Shanghai Yingjiexin Medical Technology Co., Ltd., trading as Enjosim, is a self-medication system developer dedicated to providing pen-type injection devices for biologics. It has a 300-square-foot R&D centre in Pudong, Shanghai, and 3,800-square-foot industrialized factories in Changshu and Wuxi. The technical team has over 10 years of experience in the development of self-administration systems. It has applied for 16 product patents as of 2024. In December 2025, Enjosim raised a series A+ funding from new investor Addor Capital.

The company's main business is the research and development, production and sales of self-administration systems for biomacromolecule drugs. Its products include auto-injectors, insulin pre-filled pens, automatic cosmetic injection devices, repeat injection pens, and electronic pens. Enjosim also provides patching drug delivery device and inhalation drug delivery device.

The company generates revenue by providing self-administration systems for biomacromolecule drugs, such as auto-injectors and insulin pre-filled pens.

The company will use the latest funding to further expand the construction of a global high-quality standard production capacity system and to expand the global marketing and registration team.

## Funding rounds

- Series A, Dec 25, 2025 — Addor Capital
- Series A, Sep 9, 2024, $14M — Grandway Capital, Moutai(Guizhou) Investment Management, Luminous Ventures, Yinman Fund

## Investors

- Grandway Capital (https://capitalatlas.ai/funds/grandway-capital) — Series A
- Moutai(Guizhou) Investment Management (https://capitalatlas.ai/funds/moutai-guizhou-investment-management) — Series A
- Luminous Ventures — Series A
- Yinman Fund — Series A
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A